title: Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial.
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia.
authors.forename: A C
authors.initials: AC
authors.lastname: Chen
authors.affiliation: NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: A J
authors.initials: AJ
authors.lastname: Martin
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia.
authors.forename: R A
authors.initials: RA
authors.lastname: Dalziell
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia.
authors.forename: G M
authors.initials: GM
authors.lastname: Halliday
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia.|Melanoma Institute Australia, North Sydney, Sydney, NSW, Australia.
authors.forename: D L
authors.initials: DL
authors.lastname: Damian
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005546:Forehead / Q000502:physiology; D006801:Humans; D007866:Leg / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage*; D012621:Seasons; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D014803:Vitamin B Complex / Q000008:administration & dosage*; D014870:Water Loss, Insensible / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D014803:Vitamin B Complex; D009536:Niacinamide